tumors News
Most Popular tumors Story
Novartis' Afinitor shrinks tumors in 33% of patients
Shares of Novartis were buoyed by the news that its experimental cancer drug Afinitor cut the size of tumors by half or more in a third of patients recruited for a mid-stage study. And Novartis said Read more...
Latest Headlines
- January 25, 2011
- June 3, 2008
- April 29, 2008
- March 27, 2008
- March 3, 2008
- February 21, 2008
- January 18, 2008
- December 19, 2007
- October 23, 2007
- September 27, 2007
- September 7, 2007
- August 22, 2007
- January 25, 2007
- January 15, 2007
- January 2, 2007
- November 20, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
